Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 04 tags : Disease save search
Altimmune Announces Initiation of 12-week Phase 1b Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease
Published: 2021-10-04 (Crawled : 20:00) - biospace.com/
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -2.93%
H: 1.29%
C: -2.41%
disease liver disease phase 1 liver trial phase 1b phase 2b
Inhibikase Therapeutics Announces Interim Three-month Results from Chronic Toxicology Studies of its Oral c-Abl Kinase Inhibitor, IkT-148009, in Development for Treatment of Parkinson's Disease
Published: 2021-10-04 (Crawled : 12:15) - prnewswire.com
IKT | $2.1 0.19% 52K
|
Health Technology
|
| O: 2.32%
H: 2.77%
C: -1.77%
disease treatment results parkinson ikt-148009
Tonix Pharmaceuticals Announces Completion of Acquisition of Infectious Disease R&D Center in Frederick, Maryland
Published: 2021-10-04 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: -1.67%
H: 1.49%
C: -2.88%
disease acquisition infectious disease
Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
Published: 2021-10-04 (Crawled : 11:00) - globenewswire.com
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: -0.93%
H: 0.54%
C: -1.22%
disease liver disease hepatitis nash liver diagnostic
12% CAGR Growth in Hemp-based Foods Market due to the Growing Vegan Population and Cases Of Celiac Disease | Technavio
Published: 2021-10-04 (Crawled : 10:00) - prnewswire.com
ACB | News | $6.46 -1.15% -1.16% 6.2M
|
Process Industries
|
| O: 1.15%
H: 1.07%
C: 0.28%
disease food growing growth
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
Published: 2021-10-04 (Crawled : 06:00) - globenewswire.com
GLPGF | News | $35.5157 71.75% 4.8K
|
Health Technology
|
| O: -4.52%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.09%
H: 1.21%
C: -0.94%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -1.82%
H: 0.04%
C: -1.29%
disease phase 3 enroll
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.